xconomy.com rank 188 |
Number of domains linking to xconomy.com 16 | semantic flow 2.62 |
Number of links to xconomy.com 49 | semantic flow 2.62 |
Number of domains linked from xconomy.com 91 | semantic flow 6.18 |
Number of links from xconomy.com 118 | semantic flow 6.18 |
Pages with highest topical PageRank pointing to domain.
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Xconomy: West Coast Biotech Roundup: Audentes, Fate, Zosano & More https://www.xconomy.com/national/2015/10/15/west-coast-biotech-roundup-audentes-fate-zosan | 0.28 | 0.94 | 60 | 22 | 8 | 6 | 0 | 0 | |
Xconomy: Teva Agrees to Buy San Diegou2019s Auspex Pharmaceuticals for $3B+ https://www.xconomy.com/san-diego/2015/03/30/teva-agrees-to-buy-san-diegos-auspex-pharmace | 0.21 | 0.99 | 48 | 19 | 3 | 2 | 0 | 0 | |
Xconomy: Novartis Bets $250M-Plus on Adurou2019s Immuno-Oncology Work https://www.xconomy.com/san-francisco/2015/03/30/novartis-bets-250m-plus-on-aduros-immuno- | 0.21 | 0.72 | 46 | 15 | 3 | 2 | 0 | 0 | |
Xconomy: West Coast Biotech Roundup: Auspex, Hyperion, NuVasive, & More https://www.xconomy.com/san-diego/2015/04/02/west-coast-biotech-roundup-auspex-hyperion-nu | 0.21 | 1 | 51 | 19 | 2 | 1 | 0 | 0 | |
Xconomy: Advancing Drugs at Roche, Sophiris, Coherus, and Other Bio News https://www.xconomy.com/san-diego/2015/11/13/advancing-drugs-at-roche-sophiris-coherus-and | 0.21 | 0.99 | 56 | 22 | 4 | 3 | 0 | 0 | |
Xconomy: Third Rock Gets $616M to Grow New Crop of Biotech Startups https://www.xconomy.com/boston/2016/10/31/third-rock-gets-616m-to-back-new-startups/ | 0.21 | 0.98 | 57 | 23 | 4 | 3 | 0 | 0 | |
Xconomy: Shire Acquires Meritage Pharma in Deal Potentially Worth $245M https://www.xconomy.com/san-diego/2015/02/24/shire-acquires-meritage-pharma-in-deal-potent | 0.19 | 0.98 | 53 | 20 | 4 | 3 | 0 | 0 | |
Xconomy: Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better https://www.xconomy.com/national/2011/10/24/biotech-vcs-have-a-problem-and-it-will-get-wor | 0.19 | 0.95 | 60 | 26 | 8 | 6 | 1 | 1 | |
Xconomy: One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash https://www.xconomy.com/national/2015/01/08/one-week-into-the-new-year-five-biotechs-reel- | 0.19 | 0.69 | 56 | 18 | 5 | 4 | 0 | 0 | |
Xconomy: Synlogic Gets $30M From Atlas, NEA to Turn Smart Bugs Into Drugs https://www.xconomy.com/boston/2014/07/22/synlogic-gets-30m-from-atlas-nea-to-turn-smart-b | 0.19 | 0.71 | 57 | 16 | 2 | 1 | 1 | 1 |
On-topic pages from domain with highest topical PageRank having a few outgoing links and domains.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Xconomy: West Coast Biotech Roundup: Audentes, Fate, Zosano & More https://www.xconomy.com/national/2015/10/15/west-coast-biotech-roundup-audentes-fate-zosan | 0.28 | 0.94 | 60 | 22 | 8 | 6 | 0 | 0 | |
Xconomy: Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better https://www.xconomy.com/national/2011/10/24/biotech-vcs-have-a-problem-and-it-will-get-wor | 0.19 | 0.95 | 60 | 26 | 8 | 6 | 1 | 1 | |
Xconomy: One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash https://www.xconomy.com/national/2015/01/08/one-week-into-the-new-year-five-biotechs-reel- | 0.19 | 0.69 | 56 | 18 | 5 | 4 | 0 | 0 | |
Xconomy: Watch Out SF, Boston Is Turning Into Biotechu2019s No. 1 Cluster https://www.xconomy.com/national/2012/10/08/watch-out-sf-boston-is-becoming-biotechs-no-1- | 0.19 | 0.96 | 58 | 21 | 6 | 5 | 0 | 0 |
Relevant domains with most links to selected domain.
Relevant domains with most links from selected domain.
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://www.xconomy.com/national/2011/03/07/forget-about-the-ipo-market-its-time-for-biote | 1 | 0.16 | 0.6 | 0.07 | 0.69 | yes | 54 | 13 | 3 | 2 | 1 | 1 | |
https://www.xconomy.com/xpertise/starting-a-biotech-company-what-every-entrepreneur-needs- | 1 | 0.16 | 0.91 | 0.04 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.xconomy.com/rss-feeds | 1 | 0.16 | 0.94 | 0.04 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.xconomy.com/boston | 1 | 0.16 | 0.93 | 0.04 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.xconomy.com/san-francisco | 1 | 0.16 | 0.91 | 0.04 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.xconomy.com/san-francisco/2017/12/08/in-biggest-biotech-ipo-of-2017-denali-rai | 1 | 0.15 | 0.49 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 | |
http://www.xconomy.com/boston/2013/04/19/east-coast-life-sciences-roundup-thermo-alkermes- | 1 | 0.21 | 0.62 | 0.02 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 | |
https://www.xconomy.com/san-antonio-tech-seizing-the-momentum/ | 1 | 0.16 | 0.57 | 0.02 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.xconomy.com/boston/2015/10/27/taris-2-0-a-year-after-buyout-vcs-bet-32m-more-on | 1 | 0.17 | 0.41 | 0.02 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 | |
https://www.xconomy.com/boston/2010/02/08/solace-pharma-closes-boston-area-office-after-pa | 1 | 0.16 | 0.6 | 0.01 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://www.xconomy.com/seattle | 31 | 0.16 | 0.92 | 0.04 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.xconomy.com/national/2011/03/07/forget-about-the-ipo-market-its-time-for-biote | 13 | 0.16 | 0.6 | 0.45 | 0.69 | yes | 54 | 13 | 3 | 2 | 1 | 1 | |
https://www.xconomy.com/boston | 9 | 0.16 | 0.93 | 0.04 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.xconomy.com/san-diego | 9 | 0.16 | 0.91 | 0.03 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.xconomy.com/national/2013/02/18/biotech-pharma-whining-about-talent-should-loo | 7 | 0.16 | 0.88 | 0.39 | 0.96 | yes | 61 | 21 | 6 | 5 | 1 | 1 | |
https://www.xconomy.com/san-francisco | 7 | 0.16 | 0.91 | 0.03 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.xconomy.com/boston/2014/07/22/synlogic-gets-30m-from-atlas-nea-to-turn-smart-b | 2 | 0.19 | 0.6 | 0.09 | 0.71 | yes | 57 | 16 | 2 | 1 | 1 | 1 | |
https://www.xconomy.com/xpertise/interview-with-lita-nelsen-on-the-future-of-technology-tr | 2 | 0.17 | 0.93 | 0.07 | 0.84 | yes | 43 | 14 | 3 | 2 | 0 | 0 | |
https://www.xconomy.com/xpertise/xconomy-insight-presents-starting-a-biotech-company-where | 1 | 0.17 | 0.94 | 0.06 | 0.94 | yes | 42 | 15 | 2 | 1 | 0 | 0 | |
https://www.xconomy.com/new-york | 1 | 0.16 | 0.9 | 0 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.